Insider · CIK 0001357864
Matthew Jenusaitis
Files at NVNO (enVVeno Medical Corp). First filing Dec 23, 2024, latest Dec 23, 2024.
In brief
Matthew Jenusaitis files SEC Form 4 as director at NVNO (enVVeno Medical Corp). Since Dec 23, 2024, Matthew Jenusaitis has reported 1 open-market buy worth $24k and 0 open-market sells worth $0, the latest filed on Dec 23, 2024.
A track record needs three past buys with six months of prices behind them; Matthew Jenusaitis has 0, so none is measured yet.
The newest scored trade: bought $24k of NVNO on Dec 19, 2024, filed Dec 23, 2024, scored 40 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
NVNO: enVVeno Medical Corp
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 40Moderate | enVVeno Medical Corp | $24k 9,620 shares | +139% | - |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 11, 2025 | NVNO enVVeno Medical Corp | AGrant or award Stock Optionsderivative | +135,883 | $0.00 | $0 | 135,883 | Dec 15, 2025 |
| Dec 19, 2024 | NVNO enVVeno Medical Corp | POpen-market purchase Common Stock | +9,620 | $2.53 | $24k | 16,545 | Dec 23, 2024 |
| Dec 18, 2024 | NVNO enVVeno Medical Corp | AGrant or award Stock Optionsderivative | +19,752 | $0.00 | $0 | 19,752 | Dec 20, 2024 |
Questions about Matthew Jenusaitis
Answered from the filings on this page, as of the latest one.
Is Matthew Jenusaitis buying or selling?
Not in the last 12 months. Matthew Jenusaitis's latest open-market trade on SEC Form 4 was bought $24k of NVNO on Dec 19, 2024.
How did Matthew Jenusaitis's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Matthew Jenusaitis has 0.
Where does Matthew Jenusaitis file Form 4?
Matthew Jenusaitis has filed Form 4 at NVNO (enVVeno Medical Corp). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.